Virios Therapeutics, Inc.Virios Therapeutics, Inc.Virios Therapeutics, Inc.

Virios Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.94 M‬USD
−0.2673USD
‪−5.30 M‬USD
‪23.36 M‬
Beta (1Y)
5.24

About Virios Therapeutics, Inc.

CEO
Gregory Duncan
Headquarters
Alpharetta
Website
Employees (FY)
4
Founded
2012
FIGI
BBG00X0SZKJ2
Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VIRI is 0.2500 USD — it has increased by 2.04% in the past 24 hours. Watch Virios Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Virios Therapeutics, Inc. stocks are traded under the ticker VIRI.
VIRI stock has risen by 4.17% compared to the previous week, the month change is a 8.70% rise, over the last year Virios Therapeutics, Inc. has showed a 86.91% decrease.
We've gathered analysts' opinions on Virios Therapeutics, Inc. future price: according to them, VIRI price has a max estimate of 1.00 USD and a min estimate of 0.40 USD. Watch VIRI chart and read a more detailed Virios Therapeutics, Inc. stock forecast: see what analysts think of Virios Therapeutics, Inc. and suggest that you do with its stocks.
VIRI reached its all-time high on Dec 17, 2020 with the price of 16.7100 USD, and its all-time low was 0.1557 USD and was reached on May 23, 2024. View more price dynamics on VIRI chart.
See other stocks reaching their highest and lowest prices.
VIRI stock is 8.26% volatile and has beta coefficient of 5.24. Track Virios Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Virios Therapeutics, Inc. there?
Today Virios Therapeutics, Inc. has the market capitalization of ‪6.94 M‬, it has increased by 11.21% over the last week.
Yes, you can track Virios Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Virios Therapeutics, Inc. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
VIRI earnings for the last quarter are −0.07 USD per share, whereas the estimation was −0.04 USD resulting in a −75.00% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Virios Therapeutics, Inc. earnings.
Virios Therapeutics, Inc. revenue for the last quarter amounts to 0 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
VIRI net income for the last quarter is ‪−1.29 M‬ USD, while the quarter before that showed ‪−1.10 M‬ USD of net income which accounts for −17.06% change. Track more Virios Therapeutics, Inc. financial stats to get the full picture.
No, VIRI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 15, 2024, the company has 4.00 employees. See our rating of the largest employees — is Virios Therapeutics, Inc. on this list?
Like other stocks, VIRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virios Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Virios Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Virios Therapeutics, Inc. stock shows the sell signal. See more of Virios Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.